DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (18)
     Drug Exposure During Pregnancy (6)Drug Dose Omission (4)Headache (4)more >>

Cases resulting in a serious event (15)
     Drug Exposure During Pregnancy (6)Drug Dose Omission (4)Rubella Antibody Positive (4)more >>

Cases resulting in death (1)
     Surgery (1)

Cases resulting in life threatening events (3)
     Pulmonary Embolism (2)Ligament Rupture (1)Pain (1)more >>

Cases resulting in hospitalization (4)
     Pulmonary Embolism (2)Pain (1)Retinal Vascular Thrombosis (1)more >>

Cases resulting in disability (2)
     Ligament Rupture (1)Pain (1)Post Procedural Complication (1)more >>

Cases resulting in other serious reactions (10)
     Drug Exposure During Pregnancy (6)Drug Dose Omission (4)Rubella Antibody Positive (4)more >>

Adverse event in 26 year old female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a consumer/non-health professional from United States on 2007-07-20

Patient: 26 year old female

Adverse reactions / side effects: Rubella Antibody Positive, Inappropriate Schedule of Drug Administration, Drug Dose Omission, Drug Exposure During Pregnancy, Heart Rate Increased, Amniocentesis Abnormal, Pregnancy

Suspect drug(s):
Cervidil

Claravis
    Dosage: 40 mg, bid, oral
    Administration route: Oral
    Start date: 2006-02-07
    End date: 2006-08-13

Ortho TRI-Cyclen LO
    Dosage: 1 tablet, qd, oral
    Administration route: Oral
    Indication: Oral Contraception

Other drugs received by patient: Chitosan (Poliglusam); Isotrim (Sulfamethoxazole, Trimethoprim); Vita-PAK



Adverse event in female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a consumer/non-health professional from United States on 2007-06-15

Patient: female, weighing 59.0 kg (129.7 pounds)

Adverse reactions / side effects: Drug Dose Omission, Drug Exposure During Pregnancy, Pregnancy ON Oral Contraceptive, Abortion Spontaneous

Suspect drug(s):
Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)



Adverse event in 27 year old female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a consumer/non-health professional from United States on 2007-06-15

Patient: 27 year old female, weighing 56.7 kg (124.7 pounds)

Adverse reactions / side effects: Pain, Pulmonary Embolism

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Ortho TRI-Cyclen
    Dosage: 21 day regimen 1 x day po
    Administration route: Oral
    Indication: Contraception
    Start date: 2000-01-01
    End date: 2007-04-01

Ortho TRI-Cyclen LO
    Dosage: 21 day regimen 1 x day po
    Administration route: Oral
    Indication: Contraception
    Start date: 2000-01-01
    End date: 2007-04-01

YAZ
    Dosage: 24 day regimen 1 x day po
    Administration route: Oral
    Indication: Contraception
    Start date: 2007-04-01
    End date: 2007-05-01

YAZ Bayer Healthcare
    Dosage: 24 day regimen 1 x day po
    Administration route: Oral
    Indication: Contraception
    Start date: 2007-04-01
    End date: 2007-05-01

Other drugs received by patient: Prozac; Prozac



Adverse event in receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a pharmacist from United States on 2007-06-12

Patient:

Adverse reactions / side effects: Circumstance or Information Capable of Leading TO Medication Error, Medication Error

Suspect drug(s):
Aspirin
    Dosage: tablet

Ortho TRI-Cyclen LO
    Dosage: tablet



Adverse event in 26 year old female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a consumer/non-health professional from United States on 2007-06-11

Patient: 26 year old female

Adverse reactions / side effects: Drug Dose Omission, Rubella Antibody Positive, Drug Exposure During Pregnancy, Unintended Pregnancy, Treatment Noncompliance

Suspect drug(s):
Claravis
    Dosage: 40 mg, bid, oral
    Administration route: Oral
    Start date: 2006-02-07
    End date: 2006-08-13

Ortho TRI-Cyclen LO
    Dosage: 1 tablet, qd, oral
    Administration route: Oral
    Indication: Oral Contraception

Other drugs received by patient: Chitosan (Poliglusam); Isotrim (Sulfamethoxazole, Trimethoprim); Vita-PAK



Adverse event in female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a lawyer from United States on 2007-05-16

Patient: female

Adverse reactions / side effects: Surgery

Adverse event resulted in: death

Suspect drug(s):
Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)



Adverse event in female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a physician from United States on 2007-05-02

Patient: female

Adverse reactions / side effects: Irritability, Vomiting, Nausea, Headache, Pharmaceutical Product Complaint

Suspect drug(s):
Ortho TRI-Cyclen LO
    Dosage: once daily daily po
    Administration route: Oral
    Indication: Oral Contraception
    Start date: 2007-02-01
    End date: 2007-03-09

Ortho-Novum
    Dosage: once daily daily po
    Administration route: Oral
    Indication: Oral Contraception
    Start date: 2006-11-27
    End date: 2007-01-22



Adverse event in female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a consumer/non-health professional from United States on 2007-04-13

Patient: female

Adverse reactions / side effects: Endodontic Procedure, Tonsillectomy, Breath Odour, Gastrooesophageal Reflux Disease

Suspect drug(s):
Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)



Adverse event in 26 year old female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a consumer/non-health professional from United States on 2007-04-12

Patient: 26 year old female

Adverse reactions / side effects: Drug Dose Omission, Rubella Antibody Positive, Drug Exposure During Pregnancy, Pregnancy ON Oral Contraceptive, Treatment Noncompliance

Suspect drug(s):
Claravis
    Dosage: see image
    Administration route: Oral
    Start date: 2005-12-07
    End date: 2006-01-01

Claravis
    Dosage: see image
    Administration route: Oral
    Start date: 2006-01-01
    End date: 2006-08-13

Ortho TRI-Cyclen LO
    Dosage: 1 tablet, qd, oral
    Administration route: Oral
    Indication: Oral Contraception

Other drugs received by patient: Chitosan (Poliglusam); Isotrim (Sulfamethoxazole, Trimethoprim); Vita-PAK



Adverse event in female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a physician from United States on 2007-04-02

Patient: female

Adverse reactions / side effects: Irritability, Vomiting, Nausea, Headache, Pharmaceutical Product Complaint

Suspect drug(s):
Generic Ortho Novum 7-7-7
    Dosage: once daily daily po
    Administration route: Oral
    Indication: Oral Contraception
    Start date: 2006-11-27
    End date: 2007-01-22

Ortho TRI-Cyclen LO
    Dosage: once daily daily po
    Administration route: Oral
    Indication: Oral Contraception
    Start date: 2007-02-01
    End date: 2007-03-09



Adverse event in 40 year old female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a individual with unspecified qualification from United States on 2007-03-26

Patient: 40 year old female, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Headache, Metrorrhagia

Suspect drug(s):
Ortho TRI-Cyclen
    Indication: Contraception

Ortho TRI-Cyclen LO
    Indication: Contraception



Adverse event in 26 year old female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a consumer/non-health professional from United States on 2007-03-09

Patient: 26 year old female

Adverse reactions / side effects: Rubella Antibody Positive, Drug Exposure During Pregnancy, Unintended Pregnancy, Pregnancy ON Oral Contraceptive, Treatment Noncompliance

Suspect drug(s):
Claravis
    Dosage: 40 mg, qd, oral, 80 mg, qd, oral
    Administration route: Oral
    Start date: 2005-12-07
    End date: 2006-01-01

Claravis
    Dosage: 40 mg, qd, oral, 80 mg, qd, oral
    Administration route: Oral
    Start date: 2006-01-01
    End date: 2006-08-13

Ortho TRI-Cyclen LO
    Dosage: 1 tablet, qd, oral
    Administration route: Oral
    Indication: Oral Contraception

Other drugs received by patient: Chitosan (Poliglusam); Isotrim (Sulfamethoxazole, Trimethoprim); Vita-PAK



Adverse event in female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-08

Patient: female, weighing 64.4 kg (141.7 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Intra-Uterine Death, Pregnancy ON Oral Contraceptive

Suspect drug(s):
Ortho Evra
    Indication: Contraception
    Start date: 2003-01-28

Ortho TRI-Cyclen LO
    Administration route: Oral
    Indication: Contraception



Adverse event in 27 year old female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a physician from United States on 2007-03-01

Patient: 27 year old female

Adverse reactions / side effects: Retinal Vascular Thrombosis, Brain Oedema, Headache, Papilloedema

Adverse event resulted in: hospitalization

Suspect drug(s):
Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)



Adverse event in female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a physician from United States on 2007-02-22

Patient: female, weighing 63.5 kg (139.7 pounds)

Adverse reactions / side effects: Pulmonary Embolism

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)



Adverse event in 29 year old female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a consumer/non-health professional from United States on 2007-02-06

Patient: 29 year old female

Adverse reactions / side effects: Ovarian Cyst Ruptured

Adverse event resulted in: hospitalization

Suspect drug(s):
Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)



Adverse event in female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a consumer/non-health professional from United States on 2007-02-02

Patient: female, weighing 59.0 kg (129.7 pounds)

Adverse reactions / side effects: Appendicitis

Suspect drug(s):
Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Other drugs received by patient: Claritin-D



Adverse event in 38 year old female receiving Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

Reported by a lawyer from United States on 2007-01-17

Patient: 38 year old female, weighing 70.3 kg (154.7 pounds)

Adverse reactions / side effects: Ligament Rupture, Post Procedural Complication, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Ortho TRI-Cyclen LO (Norgestimate / Ethinyl Estradiol)

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009